Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Virology

• Publication date

  2012-12-20

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.virol.2012.09.002PMID 23102968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome of low-temperature T4-related bacteriophage vB_EcoM-VR7

  2011cited by this paper
• Evolution of mosaically related tailed bacteriophage genomes seen through the lens of phage P22 virion assembly.

  2011cited by this paper
• Colonization-Induced Host-Gut Microbial Metabolic Interaction

  2011cited by this paper
• Gene Network Visualization and Quantitative Synteny Analysis of more than 300 Marine T4-Like Phage Scaffolds from the GOS Metagenome

  2010cited by this paper
• Control of Bacterial Diarrhea with Phages: Coverage and Safety Issues in Bacteriophage Therapy

  2010cited by this paper
• Mobile Regulatory Cassettes Mediate Modular Shuffling in T4-Type Phage Genomes

  2010influential reference
• Unauthorized Horizontal Spread in the Laboratory Environment: The Tactics of Lula, a Temperate Lambdoid Bacteriophage of Escherichia coli

  2010cited by this paper
• A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy

  2009cited by this paper
• In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli.

  2009cited by this paper
• T4 phages against Escherichia coli diarrhea: potential and problems.

  2009cited by this paper
• Evaluation of bacteriophages for prevention and treatment of diarrhea due to experimental enterotoxigenic Escherichia coli O149 infection of pigs.

  2009influential reference
• Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.

  2009cited by this paper
• Impact of coffee consumption on the gut microbiota: a human volunteer study.

  2009cited by this paper
• Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

  2009cited by this paper
• Critical Evaluation of Two Primers Commonly Used for Amplification of Bacterial 16S rRNA Genes

  2008cited by this paper
• ARDB—Antibiotic Resistance Genes Database

  2008influential reference
• Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex

  2008cited by this paper
• Lactobacillus rhamnosus R11 Consumed in a Food Supplement Survived Human Digestive Transit without Modifying Microbiota Equilibrium as Assessed by Real-Time Polymerase Chain Reaction

  2007cited by this paper
• VFDB 2008 release: an enhanced web-based resource for comparative pathogenomics

  2007cited by this paper
• Genome Analysis of Phage JS98 Defines a Fourth Major Subgroup of T4-Like Phages in Escherichia coli

  2007cited by this paper
• Modular architecture of the T4 phage superfamily: a conserved core genome and a plastic periphery.

  2007cited by this paper
• Bacteriophages: Biology and Applications

  2007cited by this paper
• Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy

  2005cited by this paper
• Phages and the Evolution of Bacterial Pathogens: from Genomic Rearrangements to Lysogenic Conversion

  2004cited by this paper
• Impact of Consumption of Oligosaccharide-Containing Biscuits on the Fecal Microbiota of Humans

  2004cited by this paper
• Isolation of Escherichia coli Bacteriophages from the Stool of Pediatric Diarrhea Patients in Bangladesh

  2004cited by this paper
• Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers.

  2004cited by this paper
• Bacteriophage Therapy in Humans

  2004cited by this paper
• The genome and proteome of coliphage T1.

  2004cited by this paper
• In Vitro and In Vivo Bacteriolytic Activities of Escherichia coli Phages: Implications for Phage Therapy

  2004cited by this paper
• Pharmacokinetic Principles of Bacteriophage Therapy

  2003cited by this paper
• The prospect for bacteriophage therapy in Western medicine

  2003cited by this paper
• Prophage Genomics

  2003cited by this paper
• Bacteriophage T4 Genome

  2003cited by this paper
• Phylogeny of the Major Head and Tail Genes of the Wide-Ranging T4-Type Bacteriophages

  2001influential reference
• Bacteriophage therapy.

  2001cited by this paper
• Bacteriophage Therapy

  2001cited by this paper
• The spectrum of acridine resistant mutants of bacteriophage T4 reveals cryptic effects of the tsL141 DNA polymerase allele on spontaneous mutagenesis.

  1998cited by this paper
• Genome plasticity in the distal tail fiber locus of the T-even bacteriophage: recombination between conserved motifs swaps adhesin specificity.

  1998cited by this paper
• CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

  1994cited by this paper
• Age-specific prevalence of antibody to enterotoxigenic Escherichia coli in Ecuadorian and German children.

  1990cited by this paper
• Some acridine-resistant mutations of bacteriophage T4D.

  1974cited by this paper

• Phage therapy: innovations, challenges, and future directions in combating superbugs and antibiotic resistance.

  2026cites this paper
• Management of Diabetic Foot Infections Using Phage Therapy

  2026cites this paper
• Randomized, Negative-Controlled Pilot Study on the Treatment of Intramammary Staphylococcus aureus Infections in Dairy Cows with a Bacteriophage Cocktail

  2026cites this paper
• Safety, recovery, and pharmacodynamics of CRISPR-Cas therapeutic SNIPR001: a phase 1, randomised, double-blind, first-in-human, dose-escalation study.

  2026cites this paper
• Lipid nanoparticle (LNP)-mediated cytoplasmic expression of single-stranded DNA and its application in Mpox vaccine.

  2026cites this paper
• Isolation and complete genome sequence of a novel Mycobacterium phage MS619

  2025cites this paper
• Bacteriophage therapy inspired new age technologies to control antimicrobial resistance

  2025cites this paper
• TERAPIA FÁGICA: UMA ABORDAGEM INOVADORA NO TRATAMENTO DE INFECÇÕES POR BACTÉRIAS RESISTENTES

  2025cites this paper
• Insight into Bacteriophage Therapy for Bacterial Infections and Cancer.

  2025cites this paper
• Phage therapy as a modern alternative to antibiotics

  2025cites this paper
• A T7 autogene-mediated DNA vaccine platform for SARS-CoV-2: Overcoming DNA vaccine limitations with enhanced spike mRNA production.

  2025cites this paper
• Bacteriophages: A Challenge for Antimicrobial Therapy

  2025cites this paper
• A Phage Collection Propagated in Escherichia coli K-12 Shows Broad Lytic Activity Against a Diverse Panel of Multidrug-Resistant Isolates

  2025cites this paper
• Gp38 adhesins of Straboviridae phages recognize specific extracellular loops of outer membrane protein receptors

  2025cites this paper
• Implications of gut microbiota-mediated epigenetic modifications in intestinal diseases

  2025cites this paper
• Isolation and characterization of Septuagintavirus; a novel clade of Escherichia coli phages within the subfamily Vequintavirinae

  2024cites this paper
• Mini review advantages and limitations of lytic phages compared with chemical antibiotics to combat bacterial infections

  2024cites this paper
• Bacteriophages: a double-edged sword in the gastrointestinal tract

  2024cites this paper
• Dietary Bacteriophage Administration Alleviates Enterotoxigenic Escherichia coli-Induced Diarrhea and Intestinal Impairment through Regulating Intestinal Inflammation and Gut Microbiota in a Newly Weaned Mouse Model

  2024cites this paper
• Phage therapeutic delivery methods and clinical trials for combating clinically relevant pathogens.

  2024cites this paper
• Three novel Enterobacter cloacae bacteriophages for therapeutic use from Ghanaian natural waters

  2024cites this paper
• Safety and Tolerability of ShigActive™, a Shigella spp. Targeting Bacteriophage Preparation, in a Phase 1 Randomized, Double-Blind, Controlled Clinical Trial

  2024cites this paper
• Characterization of two lytic bacteriophages infecting carbapenem-resistant clinical Klebsiella pneumoniae in Dhaka, Bangladesh

  2024cites this paper
• Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections

  2024cites this paper
• Bacteriophage–Host Interactions and the Therapeutic Potential of Bacteriophages

  2024cites this paper
• Bacteriophages in the fish mucosa: updates on their biology, interactions, and applications

  2024cites this paper
• Stability Considerations for Bacteriophages in Liquid Formulations Designed for Nebulization

  2023cites this paper
• Characterization of bacteriophage BUCT631 lytic for K1 Klebsiella pneumoniae and its therapeutic efficacy in Galleria mellonella larvae

  2023cites this paper
• The Novel Role of Phage Particles in Chronic Liver Diseases

  2023cites this paper
• The Future of Clinical Phage Therapy in the United Kingdom

  2023cites this paper
• Non-traditional approaches for control of antibiotic resistance

  2023cites this paper
• The Potential of Bacteriophage-Antibiotic Combination Therapy in Treating Infections with Multidrug-Resistant Bacteria

  2023cites this paper
• Dynamic modelling of bacteriophage production process

  2023cites this paper
• Phage therapy: Awareness and demand among clinicians in the United Kingdom

  2023cites this paper
• Development of a Replication-Deficient Bacteriophage Reporter Lacking an Essential Baseplate Wedge Subunit

  2023cites this paper
• Phages for treatment of Escherichia coli infections.

  2023cites this paper
• Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes?

  2023cites this paper
• Modulation of Caecal Microbiota and Metabolome Profile in Salmonella-Infected Broilers by Phage Therapy

  2023cites this paper
• A Taxonomy-Agnostic Approach to Targeted Microbiome Therapeutics—Leveraging Principles of Systems Biology

  2023cites this paper
• Bacteriophage: A new therapeutic player to combat neutrophilic inflammation in chronic airway diseases

  2022cites this paper
• Encapsulation and delivery of phage as a novel method for gut flora manipulation in situ: A review.

  2022cites this paper
• Phage therapy: current review and future perspectives

  2022cites this paper
• Tracking the phage trends: A comprehensive review of applications in therapy and food production

  2022cites this paper
• Do we need nasal vaccines against COVID 19 to suppress the transmission of infections?

  2022cites this paper
• PhageScore-based analysis of Acinetobacter baumannii infecting phages antibiotic interaction in liquid medium

  2022cites this paper
• Phage Therapy: A Different Approach to Fight Bacterial Infections

  2022cites this paper
• Biological foundations of successful bacteriophage therapy

  2022cites this paper
• Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation.

  2022cites this paper
• Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans

  2022cites this paper
• Current Status of Phage Therapy against Infectious Diseases and Potential Application beyond Infectious Diseases

  2022cites this paper
• Phage Therapy

  2022cites this paper
• Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain

  2022cites this paper
• The potential of bacteriophage therapy in the treatment of paediatric respiratory infections.

  2022cites this paper
• Safety and Efficacy of an AIEC-targeted Bacteriophage Cocktail in a Mice Colitis Model.

  2022cites this paper
• Shigella viruses Sf22 and KRT47 require outer membrane protein C for infection.

  2022cites this paper
• Reassessment of Historical Clinical Trials Supports the Effectiveness of Phage Therapy

  2022cites this paper
• Immunological and safety profile of bacteriophage therapy: A pre‐clinical study

  2022cites this paper
• Enterobacteriaceae Therapy using Bacteriophages: A Review

  2022cites this paper
• Phage Therapy: A Different Approach to Fight Bacterial Infections

  2022cites this paper
• The Safety and Efficacy of Phage Therapy: A Systematic Review of Clinical and Safety Trials

  2022cites this paper
• Predicting the Future: Phage Therapy

  2022cites this paper
• Recent Advances in Multifunctional Hydrogels for the Treatment of Osteomyelitis

  2022cites this paper
• Phage therapy for diabetic foot infection

  2022cites this paper
• Deploying Viruses against Phytobacteria: Potential Use of Phage Cocktails as a Multifaceted Approach to Combat Resistant Bacterial Plant Pathogens

  2022cites this paper
• Bacteriophages and their potential for treatment of gastrointestinal diseases

  2021cites this paper
• In Vitro and In Vivo Assessment of the Potential of Escherichia coli Phages to Treat Infections and Survive Gastric Conditions

  2021cites this paper
• Microbiome and cancer.

  2021cites this paper
• Tailed Lytic Bacteriophages of Soft Rot Pectobacteriaceae

  2021cites this paper
• Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?

  2021cites this paper
• Lytic Bacteriophages Against Bacterial Biofilms Formed by Multidrug-Resistant Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus Isolated from Burn Wounds

  2021cites this paper
• Application of a novel phage ZPAH7 for controlling multidrug-resistant Aeromonas hydrophila on lettuce and reducing biofilms

  2021cites this paper
• Isolation, characterization and biocontrol efficacy of a T4-like phage virulent to multidrug-resistant Enterobacter hormaechei.

  2021cites this paper
• Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis

  2021cites this paper
• Bacteriophage therapy: Recent developments and applications of a renaissant weapon.

  2021cites this paper
• Advances in Phage Therapy: Targeting the Burkholderia cepacia Complex

  2021cites this paper
• Bacteriophages as tools for biofilm biocontrol in different fields

  2021cites this paper
• Mycobacteriophages for Drug-Resistant Tuberculosis Treatment

  2021cites this paper
• Shopping for phages? Unpacking design rules for therapeutic phage cocktails.

  2021cites this paper
• Advances in Bacteriophage Therapy against Relevant MultiDrug-Resistant Pathogens

  2021cites this paper
• Biochemical and genomic characterization of a novel bacteriophage BUCT555 lysing Stenotrophomonas maltophilia.

  2021cites this paper
• The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies

  2021cites this paper
• The Safety and Toxicity of Phage Therapy: A Review of Pre-Clinical and Clinical Studies

  2021cites this paper
• Antibiotics at the crossroads – Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance?

  2021cites this paper
• Bacteriophage-Mediated Horizontal Gene Transfer: Transduction

  2021cites this paper
• Influence of Non-canonical DNA Bases on the Genomic Diversity of Tevenvirinae

  2021cites this paper
• Modification of Bacteriophages to Increase Their Association with Lung Epithelium Cells In Vitro

  2021cites this paper
• Current State and Promising Opportunities on Pharmaceutical Approaches in the Treatment of Polymicrobial Diseases

  2021cites this paper
• Bi- and Multi-directional Gene Transfer in the Natural Populations of Polyvalent Bacteriophages, and Their Host Species Spectrum Representing Foodborne Versus Other Human and/or Animal Pathogens

  2021cites this paper
• Manufacturing of bacteriophages for therapeutic applications.

  2021cites this paper
• Bacteriophages as an Alternative Method for Control of Zoonotic and Foodborne Pathogens

  2021cites this paper
• Comparison of single and multi-host enrichment approach for harnessing lytic phages against antimicrobial-resistant E. coli: Repurposing the enrichment step

  2021cites this paper
• Does over a century of aerobic phage work provide a solid framework for the study of phages in the gut?

  2021cites this paper
• Intestinal virome and therapeutic potential of bacteriophages in liver disease.

  2021cites this paper
• Clinical Trials of Bacteriophage Therapeutics

  2021cites this paper
• Phagetherapy: Clinical Applications – Critical Appraisal of Randomized Controlled Trials

  2020cites this paper
• Bacteriófagos y endolisinas en la industria alimentaria

  2020cites this paper
• The Safety and Efficacy of Phage Therapy for Superficial Bacterial Infections: A Systematic Review

  2020cites this paper
• Bacteriophage therapy for infections in CF

  2020cites this paper
• Bacteriophages as Therapeutic Preparations: What Restricts Their Application in Medicine

  2020cites this paper
• Phage Therapy as a Novel Strategy in the Treatment of Urinary Tract Infections Caused by E. Coli

  2020cites this paper